118 related articles for article (PubMed ID: 26753456)
1. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
[TBL] [Abstract][Full Text] [Related]
2. Association study of cytochrome P450 1A1*2A polymorphism with prostate cancer risk and aggressiveness in Croatians.
Mandić S; Horvat V; Marczi S; Lukić I; Galić J
Coll Antropol; 2014 Mar; 38(1):141-6. PubMed ID: 24851608
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer.
Ianni M; Porcellini E; Carbone I; Potenzoni M; Pieri AM; Pastizzaro CD; Benecchi L; Licastro F
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):56-61. PubMed ID: 22850906
[TBL] [Abstract][Full Text] [Related]
4. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
5. Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.
Abed AS; Mokdad-Gargouri R; Raoof WM
Mol Biol Rep; 2023 Feb; 50(2):1157-1165. PubMed ID: 36417078
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
8. Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.
Bandil K; Singhal P; Dogra A; Rawal SK; Doval DC; Varshney AK; Bharadwaj M
Inflamm Res; 2017 Dec; 66(12):1085-1097. PubMed ID: 28993831
[TBL] [Abstract][Full Text] [Related]
9. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between TNF-alpha promoter polymorphism and prostate carcinoma susceptibility in eastern Croatian population.
Horvat V; Sudarević B; Cosić I; Milicević N; Bosnjak S; Mandić S; Marczi S; Simunović D; Galić J
Coll Antropol; 2013 Dec; 37(4):1199-202. PubMed ID: 24611335
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
[TBL] [Abstract][Full Text] [Related]
13. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
14. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
15. Association of interleukin gene polymorphisms with the risk of coronary artery disease.
Yang HT; Wang SL; Yan LJ; Qian P; Duan HY
Genet Mol Res; 2015 Oct; 14(4):12489-96. PubMed ID: 26505399
[TBL] [Abstract][Full Text] [Related]
16. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
18. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
[TBL] [Abstract][Full Text] [Related]
20. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
